Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8367734 | ARMSTRONG PHARMS | Stable epinephrine suspension formulation with high inhalation delivery efficiency |
Jan, 2026
(2 years from now) |
Drugs and Companies using EPINEPHRINE ingredient
Market Authorisation Date: 07 November, 2018
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic